Entera Bio Ltd. (ENTX)
NASDAQ: ENTX
· Real-Time Price · USD
1.82
0.03 (1.68%)
At close: Sep 26, 2025, 3:55 PM
1.82
0.00%
After-hours: Sep 26, 2025, 04:10 PM EDT
1.68% (1D)
| Bid | 1.8 |
| Market Cap | 83.11M |
| Revenue (ttm) | 166K |
| Net Income (ttm) | -5.47M |
| EPS (ttm) | -0.26 |
| PE Ratio (ttm) | -7 |
| Forward PE | -2.69 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 1.91 |
| Volume | 67,342 |
| Avg. Volume (20D) | 132,996 |
| Open | 1.78 |
| Previous Close | 1.79 |
| Day's Range | 1.78 - 1.92 |
| 52-Week Range | 1.50 - 2.79 |
| Beta | 1.69 |
| Ex-Dividend Date | n/a |
About ENTX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ENTX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ENTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+10.75%
Entera Bio shares are trading higher after the com...
Unlock content with
Pro Subscription
6 months ago
+3.72%
Entera Bio shares are trading higher after entering a collaboration agreement with OPKO Health to advance a GLP-1/Glucagon candidate.
